Ansøgeren konkluderede, at en optimal dosis Rapinyl giver en hurtig virkning af analgesi, som afspejler profilen for gennembrudssmerter ved cancer.
The Applicant concluded that an optimal dose of Rapinyl provides a rapid onset of analgesia which mirrors the profile of cancer breakthrough pain.